The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
It would surprise me if a number of quick return, speculative traders hadn’t moved their capital into SYME earlier today. It is currently undergoing the kind of meteoric rise that we witnessed in Nanosynth twelve days ago. Alternatively there are other options, with which they could turn another quick profit.
Investment will return here as soon as Mr. Duffin has sales figures and pending contracts to substantiate our recent optimism.
I am out for the time being, but I’ll be back.
Regards and best wishes to all Nanosynth investors
ian12.
This is your first SYME comment in 30 days. You are evidently not invested? Why are you wasting space here?
Regards.
Buger off Bugerboy31.
You stick with your negative predictions. All shareholders will remain optimistic regarding this company’s bright future.
Regards.
An incredible rise in a short time. The SYME shareholding in my trading account has now broken even and is starting to accumulate profit. The rest of my shares are in an ISA account. I purchased them @ 0.145p last week. They are currently £5K in profit. An amazing turnaround. I would be further reassured if an RNS supporting the abrupt change were to materialise.
I have been expecting this share price turnaround, and sharp rise, but later in time (Q1 2022). All we now need is a succession of expected RNS announcements to underpin the rise and to give it credibility.
Today would be perfect for an initial news release as it would sustain the rise, and keep the momentum going until Friday.
I managed to complete a lucky buy earlier today when the price was still at 0.14p per share. This was my final buy in anticipation of a substantial rise during Q1 2022. I did not expect such an abrupt share price increase subsequently. We will find out soon enough whether there is any substance to it? If this proves to be the case, we will probably hear something from the company before the markets close at midday on Christmas Eve.
fsgreuk.
I have just fact checked your claims, and it is you who is somewhat confused about the timeline of this business. It is an undisputed fact that the share price has been in linear decline (with some short term spiking) for a year. I should add that I have seen this in other embryonic businesses in the past. Most of these have recovered well and realised gains for long term investors. That is not to say that this will happen here. As an investor, I believe that this will be the case here (a reasoned view based on my research), but there are no guarantees. I wish you well, but do check your facts before posting. Incorrect information can mislead new investors, who are unconfident about carrying out their own research.
Regards.
https://www.hl.co.uk/shares/shares-search-results/s/supply@me-capital-plc-ord-0.002p-reg-s
I have changed my mind about waiting for the share price to decline into the 20 - 25p range again. Although I would not invest in IQE to the same extent as before, I took a small speculative punt within my trading account last week. 10K shares @ 31.4p, with a sell order @ 40p within three months seems a reasonable low-risk speculative trade bearing in mind the cyclical nature of this share. I might even double my stake this week?
Moreover, having an industry expert at the helm very soon should attract new investors and boost the share price. One of the most positive aspects of this company is that it has created a lot of jobs in West Wales. Moreover, I have read on LinkedIn that IQE employees are encouraged to develop their careers, and subsequently progress to better jobs elsewhere. All this is positive, but the board have not yet created an investable company for the long term. After all these years, individuals like myself should not be treating a company that manufactures fundamental components for major products in an industry worth tens of billions of pounds in such a cavalier manner. In my opinion , the company’s business strategy will need to be adjusted to access the potential profitability available for IQE’s components.
I wish all long term IQE investors good fortune in the coming years.
I scarcely believed what I was reading when scanning an article about the trialling of an anti-viral Covid treatment this morning. Synairgen has completed its Sprinter trial. Moreover, it has progressed seamlessly to Phase III of the NIAID ACTIV-2 trial. The USA are showing some interest with two positive interviews this week. But nothing, nada, zero, zilch from the UK Government or the British media? Are they seriously unaware that the outcome of a major trial of a potentially transformational Covid-19 antiviral is due within a month? Is there a conspiracy afoot to keep the share price at the current level to enable a major pharmaceutical company to buy out Synairgen at a relatively low price? Or are all contributors to this board members of a secret society with access to privileged information that most of the World knows nothing about? We will find out soon enough.
Part of an article from this morning’s Telegraph newspaper:
Boris Johnson has been accused of botching the rollout of antiviral drugs that prevent hospitalisation, with a crucial government-backed trial struggling to gain participants.
Patients have been eligible to sign up to receive molnupiravir, the first at-home Covid treatment, for more than 10 days.
It was hoped more than 10,000 people would sign up - yet, despite soaring cases, only 391 have done so.
Senior Tories have complained of “inertia” around the rollout, saying the Prime Minister should have used his Downing Street press conferences to champion the drug.
The pills are being sent out to people aged 50 and over with symptomatic Covid and a positive PCR test, plus those aged 18 and over with certain pre-existing conditions.
Previous trials have suggested that molnupiravir may be about 30 per cent effective at preventing severe disease in people who otherwise would be hospitalised, which scientists hope will make a significant contribution to managing the pandemic.
Critics believe ministers have failed to drive progress in antivirals with the same urgency as seen in the vaccine programme, despite their potential benefits being known for over a year.
A second antiviral, paxlovid - which unlike molnupiravir was designed specifically to treat Covid - has been described as a “wonder drug”, demonstrating more than 90 per cent efficacy in trials.
However, it cannot currently be rolled out because it is waiting regulatory approval from the Medicines and Healthcare products Regulatory Agency.
Thank you Private Ryan and red381.
You have both offered me useful advice. Perhaps I was too presumptuous when I set up that sell order. A case of trying to out - guess the market, which has sometimes worked for me, but more often than not, I have been wrong. A good profit is always welcomed, but in this case perhaps there is more profit available than I am anticipating? I intend to reflect seriously on this over the weekend.
Regards and good wishes.
I topped up recently. 100K shares @ 6p. I also set a sell order for my entire holding. 600K shares @ 11p. This is because this share, although not an AIM share, too often behaves as though it belonged in the AIM market.
Too often, we have seen the share price take off only to quickly fall away. I hope that this doesn’t happen here. My strategy, it it works will yield a profit of around £18K (38%) and perhaps a subsequent opportunity to reinvest at a lower price? I will have no complaints should I reach my current target, although I may lose out on a greater reward when the share price rises?
Thank you Trek,
This is a good although underused bulletin board. It is always reassuring when others, like yourself, who have undertaken similar research to my own, arrive at a similar viewpoint. Some contributors, who are very well versed in the technological aspects of IB’s products and their future potential, have also shared valuable information on this board.
Rightly or wrongly, I saw Trevor Brown’s recent repositioning of his assets as a buy signal? Is Max Brown, who is apparently an 18 year old student, Trevor Brown’s son or his grandson? I only ask that question, as it seems likely that Trevor Brown has retained control of those assets, while giving himself the potential to increase his stake in the company, without compromising himself.
The recent feel good RNS message from IB’s CEO, which lacked the substance to promote market interest, gave investors a foretaste of what will follow, early next year perhaps?
I remain optimistic about the future long term potential of this company.
Regards and good wishes.
A good morning to all SYME investors.
Lseking gave me a good piece of advice yesterday, and I intend to act on it. I will no longer interact with individuals, who contribute negativity to this board. I have a strong belief that this investment will eventually produce a good return. Consequently, I will only contribute information to back my case.
A non-investor on this board asked me for investment advice yesterday. That made me laugh. I am far from qualified to do that, and if I were able to do so, I would set up a business and profit from it. On the other hand, I received a long phone call from an investment company last week. The trainee broker that I spoke to was polite and pleasant. However, it soon became clear to us both, that for the time he knows less than I do about investing. He was informative about what his company offered without being ”pushy” in any way. We will speak again sometime next year when I will set up a dividend portfolio to generate another regular source of income.
Below is a link to the SYME website. It gives a brief account for the case for investment, which incidentally was my starting point prior to investment.
It would be useful if those who choose to write unsubstantiated drivel about SYME, would criticise this model instead. That is if they have the ability to do so? I would be interested to read their non-investment case if they have one? There will always be individuals of a similar outlook on all bulletin boards. Unfortunately, they never engage in reasoned debate. They are a bit like the climate protesters. Those people prefer to engage in negativity. They disrupt the smooth running of the country by glueing themselves to roads, buildings and vehicles rather than debate their case. Our disrupters here are of the same mindset.
I am heading out now, on a dry sunny day for a long walk around the coastal stretch close to Clevedon. My best wishes to all SYME investors. Have a great day.
https://www.supplymecapital.com/what-we-do/
superritch
"After that interview it could go quite a bit lower...mr market doesn’t like "delays "”
What "delays"? I agree that this has been the case in the past and the share price has reduced considerably as a consequence. However, the current end of the Sprinter clinical trial schedule of last patient dosed; completed results handed to the company; production of detailed statistical analysis and comments; and subsequently an announcement regarding the quality of the results is currently on time.
Synairgen has a first class leadership team at its disposal. I have high expectations that the crucial results announcement will be rapidly followed by notification of EUAs, and news of the manufacturing and distribution timelines. It is in everyone's interest that this process is expedited during Q1 2022.
Regards and good wishes.
TheDonofDons
Thank you for your reply yesterday evening. Our opinions are diametrically opposite, but I wish you well in whatever you are trying to achieve in your dire negativity. I look forward to developments in the coming year, when I suspect you will no longer be gracing this board with your presence.
I would drop the patronising "toodle pip" if I were you. It is a term mostly used by alumni of minor public schools, who have failed to live up to the excessive expectations of their parents.
Regards, and good wishes.
"Try ‘Investors of SYME’….talking about their investments and the company’s progress on a board designed for SHAREHOLDERS!!!"
I concur with Hughez87, and am grateful for all the positive information supplied here this evening. I have spent some time on Proactive Investors researching SYME earlier, and this has reinforced my confidence in the company and the systems that it is utilising to bring about inventory monetisation. It is a complex and layered business and when revenues increase, the share price will quickly escalate away from the current year low trading range.
Back to Hughez87's comment above. Could we agree to divide the comments into two main threads these being"Investors in SYME" and "Non-investors in SYME"? This would enable the non-investors to continue with their negativity and disparaging remarks, and spend their time moaning to each other about how poor an investment SYME is. The rest of us could enjoy an untroubled conversation only concerned with our investment, without having to parry away the constant negative contributions. The two threads could be kept separate and never the twain shall meet.
How about giving it a try? This is supposed to be a board for SYME investors. A fellow investor commented earlier that he rarely visits this board as it is too often like landing in a nest of vipers.
BrassGemini.
Rinse and repeat time.
All investors realise by now that you only post on here to promote your short term selling activity. Now, I am repeating myself, which makes me as boring as you are proving to be over time.
Regards.
Hello again poorinvestor.
Like you, I topped up here recently, effectively to transfer my holding into my stocks and shares ISA in anticipation of a major reversal to the current downturn in the share price.
We are encountering a lot of comments here from individuals who are attempting to discourage investors, probably to promote their short term selling activities. One of them, who goes by the name of “The DonofDons” finds the mathematics of investing very challenging. He only needs to look at the London Stock Exchange SYME page to find accurate information to assist his unsuccessful attempts at discouraging investors, and promoting his short term selling activities.
https://www.londonstockexchange.com/stock/SYME/supply-me-capital-plc/company-page
Regards and good wishes.
LexLugar208.
I concur with your sensible and well reasoned statement. When the company starts to deliver on its promises, investor confidence will grow, and the current slide in share price will reverse.
It is as unreasonable to constantly reiterate the positive points as regards this investment, as it is to repeat obvious observations about the continuing decline in the share price.
Everything rests on the company’s ability to deliver on its promises. When that happens, investors will be rewarded for their patience. Until then, there is little point in reiterating the same positivity several times a day, or indeed the same doom and gloom forecasts if one happens to be a short term seller.
Regards and good wishes.
peas123 and Havoc3852.
So this was merely a random date - the consequence of an invitation to doubters from a fellow investor. Thank you for that clarification. I also look forward to positive developments with this investment during the coming six months.
Regards and good wishes.